TABLE 3.
Two agents, Multiple endpoints (DLT, Response)
Defined by an acceptable toxicity profile (≤25% DLT rate) and the highest clinical response rate
Stop when an 11th participant recommended to a dose combination that already has 10 participants
Maximum total accrual set at 28, 1000 simulations
| Scenario | (true %DLT, true %Response) % combination recommended Avg # pts treated on combination |
Avg Size, %-tiles | % stop | % DLT | % Rsp | |||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Agent A (mg per day) | Agent B (mg per day)
|
|||||||
| 280 | 420 | 560 | ||||||
|
| ||||||||
| 1 “Ideal” | 400 | (0.07, 0.55) | (0.15, 0.70) | (0.25,0.95) | 19.1, | |||
| 0.12 | 0.12 | 0.67 | 25th = 17 | 0.2 | 16.4 | 74.2 | ||
| 1.72 | 2.30 | 7.46 | 50th = 18 | |||||
|
|
||||||||
| 200 | (0.05, 0.40) | (0.07, 0.55) | (0.15,0.80) | 75th = 20 | ||||
| 0.07 | 0.08 | 0.14 | 90th = 24 | |||||
| 2.30 | 2.30 | 3.06 | 95th = 27 | |||||
|
| ||||||||
| 2 “Worst” | 400 | (0.25, 0.25) | (0.30, 0.40) | (0.40,0.50) | 18.1, | |||
| 0.06 | 0.08 | 0.06 | 25th = 16 | 7.0 | 25.6 | 38.3 | ||
| 2.54 | 2.18 | 1.63 | 50th = 18 | |||||
|
|
||||||||
| 200 | (0.20, 0.25) | (0.25, 0.40) | (0.30,0.50) | 75th = 21 | ||||
| 0.19 | 0.36 | 0.17 | 90th = 25 | |||||
| 3.81 | 5.08 | 3.08 | 95th = 27 | |||||
|
| ||||||||
| 3 Best Guess | 400 | (0.12, 0.55) | (0.18, 0.80) | (0.25,0.95) | 19.8, | |||
| 0.02 | 0.10 | 0.58 | 25th = 17 | 0.6 | 18.4 | 75.0 | ||
| 1.97 | 2.77 | 6.72 | 50th = 18 | |||||
|
|
||||||||
| 200 | (0.10, 0.40) | (0.15, 0.55) | (0.20,0.80) | 75th = 22 | ||||
| 0.07 | 0.08 | 0.16 | 90th = 26 | |||||
| 2.57 | 2.77 | 3.16 | 95th = 28 | |||||
|
| ||||||||
| 4 “Plateau” | 400 | (0.25, 0.35) | (0.30, 0.50) | (0.40,0.50) | 18.2, | |||
| 0.06 | 0.08 | 0.03 | 25th = 17 | 9.0 | 25.7 | 44.8 | ||
| 2.55 | 2.19 | 1.46 | 50th = 18 | |||||
|
|
||||||||
| 200 | (0.20, 0.35) | (0.25, 0.50) | (0.30,0.50) | 75th = 21 | ||||
| 0.20 | 0.38 | 0.15 | 90th = 25 | |||||
| 3.83 | 5.47 | 2.92 | 95th = 28 | |||||
|
| ||||||||
| 5 “Toxic” | 400 | (0.30, 0.40) | (0.40, 0.50) | (0.50,0.75) | 18.4, | |||
| 0.09 | 0.09 | 0.03 | 25th = 16 | 11.8 | 32.9 | 52.9 | ||
| 2.94 | 2.20 | 1.10 | 50th = 19 | |||||
|
|
||||||||
| 200 | (0.25, 0.40) | (0.30, 0.50) | (0.40,0.75) | 75th = 23 | ||||
| 0.26 | 0.25 | 0.17 | 90th = 26 | |||||
| 4.41 | 4.59 | 3.12 | 95th = 28 | |||||
|
| ||||||||
| 6 “Very Toxic” | 400 | (0.75, 0.40) | (0.85, 0.50) | (0.95,0.75) | 4.3, | |||
| 0.00 | 0.00 | 0.00 | 25th = 2 | 100.00 | 74.0 | 42.5 | ||
| 0.95 | 0.09 | 0.00 | 50th = 2 | |||||
|
|
||||||||
| 200 | (0.70, 0.40) | (0.75, 0.50) | (0.85,0.75) | 75th = 6 | ||||
| 0.00 | 0.00 | 0.00 | 90th = 9 | |||||
| 1.98 | 1.07 | 0.17 | 95th = 11 | |||||
Notation:
Average (avg); percentiles (%-tiles); Response (Rsp); Average trial sample size (avg size); Percent of trials stopped early for safety (% stop); Percent of DLTs (% DLT); Percent of responses (% Rsp)